Hester Biosciences Ltd share price logo

Hester Biosciences Ltd Share Price

NSE: HESTERBIO

BSE: 524669

Small Cap

Healthcare Sector

₹1603.70

-25.90

(-1.59%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Hester Biosciences Ltd Stock Performance

as on November 4, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,599.1
    ₹1,637.8
    downward going graph

    0.29%

    Downside

    2.13%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,242.95
    ₹2,786.1
    downward going graph

    22.49%

    Downside

    73.73%

    Upside

    downward going graph

Hester Biosciences Ltd share price movements today

Previous Close
₹1,629.60
Open
₹1,635.60
Volume
2,149.00
Upper Circuit
₹1,955.50
Lower Circuit
₹1,303.70
Day's Low - High
₹1,599.1 - ₹1,637.8
52 Week Low - High
₹1,242.95 - ₹2,786.1

Hester Biosciences Ltd Historical Returns

1 Month Return
-10.6 %
3 Month Return
-20.82 %
1 Year Return
-33.22 %
3 Year Return
-19.36 %
5 Year Return
-11.72 %

Hester Biosciences Ltd Fundamentals

as on November 4, 2025 at 4:01 pm IST

Market Cap

₹1,364.25 Cr

Return on Equity (ROE)

9.77

PE Ratio (TTM)

35.31

Return on capital employed (ROCE)

9.47

Industry PE ratio

42.27

Beta (LTM)

0.73

P/B Ratio

3.15

Dividend Yield

0.56

PEG Ratio

1.8

Quarterly Earnings Growth YOY

130.97

EPS (TTM)

33.89

Sector

Pharmaceuticals

Book Value

369.41

Technical Analysis

Bearish

View Technical Analysis

Hester Biosciences Ltd Stock Valuation

as on November 4, 2025 at 4:01 pm IST

Hester Biosciences Ltd in the last 5 years

  • Overview

  • Trends

Lowest (19.52x)

March 23, 2020

Today (35.31x)

November 4, 2025

Industry (42.27x)

November 4, 2025

Highest (124.52x)

July 26, 2024

LowHigh

Today’s Price to Earnings Ratio: 35.31x

Hester Biosciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Hester Biosciences Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Hester Biosciences Ltd image
Hester Biosciences Ltd
NA1,364.25-2.34%0.7428311
ERIS Lifesciences Ltd image
ERIS Lifesciences Ltd
BUY21,807.7942.13%0.763742,908
Sanjivani Paranteral Ltd image
Sanjivani Paranteral Ltd
NA260.80437.54%0.61870
Godavari Drugs Ltd image
Godavari Drugs Ltd
NA64.3326.94%0.004113
Acutaas Chemicals Ltd image
Acutaas Chemicals Ltd
BUY15,017.6258.47%0.511601,006
See all

Hester Biosciences Ltd Stock’s Investor Sentiment and Interest

Search interest for Hester Biosciences Ltd Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:6% versus previous 30 day period

Hester Biosciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
74.94
67.3
87.85
70.46
66.98
79.26
82.27
83.69
63.22
81.93
84.11
Other Income
6.37
3.49
2.52
5.91
2.2
4.63
2.09
2.8
8.78
-5.64
3.37
Total Income
81.31
70.78
90.37
76.36
69.18
83.88
84.35
86.49
72
76.29
87.47
Expenses
56.19
55.62
73.49
57.24
56.83
63.33
64.62
64.53
58.16
62.74
61.29
Operating Profit
18.75
11.68
14.36
13.22
10.15
15.93
17.65
19.16
5.06
19.19
22.82
Operating Profit Margin %
25.02%
17.36%
16.35%
18.76%
15.15%
20.1%
21.45%
22.89%
8%
23.42%
27.13%
Profit Before Interest, Tax and Depreciation
25.13
15.16
16.88
19.12
12.35
20.55
19.74
21.96
13.85
13.54
26.18
Interest
3.89
1.37
2.57
8.08
2.19
6.94
5.01
5.89
-3.81
5.62
1.81
Depreciation
5.24
5.37
5.4
4.28
3.75
3.74
4.13
4.2
4.29
4.18
4.18
Profit Before Tax
16
8.42
8.91
6.76
6.41
9.87
10.6
11.87
13.37
3.74
20.19
Tax Paid
3.84
2.71
2.2
2.72
2.4
3.47
3.11
3.48
1.96
2.2
2.9
Profit After Tax
12.16
5.71
6.71
4.04
4.02
6.4
7.49
8.39
11.41
1.54
17.3
Total Net profit including share of profit / Loss from associate company
12.16
5.71
6.71
4.04
4.02
6.4
7.49
8.39
11.41
1.54
17.3
EPS
14.29
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
Actual EPS
14.29
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
Adjusted EPS
14.29
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
Diluted EPS
14.29
6.72
7.89
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33

Hester Biosciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
121.02
132.6
178.07
183.27
214.33
235.01
266.09
304.55
311.1
Other Income
0.42
2.55
7.21
6.37
4.68
14.16
19.56
15.25
8.02
Total Income
123.53
138.49
185.28
189.63
219.02
249.17
285.65
319.79
319.13
Expenses
82.09
88.68
110.03
127.87
149
175.02
215.48
250.89
250.05
Operating Profit
38.93
43.92
68.04
55.4
65.33
59.99
50.61
53.66
61.05
Operating Profit Margin %
32.17%
33.12%
38.21%
30.23%
30.48%
25.53%
19.02%
17.62%
19.62%
Profit Before Interest, Tax and Depreciation
41.44
49.82
75.25
61.77
70.02
74.15
70.17
68.9
69.08
Interest
3.5
4.04
6.63
7.37
6.6
4.06
9.32
19.78
12.7
Depreciation
7
9.66
11.76
13.07
13.31
16.58
20.7
17.17
16.8
Profit Before Tax
30.94
36.12
56.86
41.33
50.11
53.51
40.15
31.95
39.58
Tax Paid
8.14
13.06
16.16
10.33
15.41
14.01
12.12
10.79
10.74
Profit After Tax
22.79
23.07
40.69
31
34.7
39.48
28.04
21.17
28.83
Total Net profit including share of profit / Loss from associate company
22.79
23.07
40.69
31
34.7
39.48
28.04
21.17
28.83
EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
Actual EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
Adjusted EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
Diluted EPS
26.79
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89

Hester Biosciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
18.85
34.8
38.02
46.71
36.77
58.05
8.71
23.6
48.18
64.51
Cash Flow from Investing Activities
0.59
0.06
-2.82
1.61
0.86
-1.35
-21.07
0.82
1.95
1.08
Cash Flow from Financing Activities
-6.69
1.83
-11.08
2.64
18.74
-18.23
111.55
41.75
-26.1
-51.72
Net Cash Flow
-1.14
6.45
1.15
28.32
-17.12
-2.26
3.48
-11.59
-0.36
-6.72

Mutual Funds that own Hester Biosciences Ltd Stock

Check out the Mutual Funds with significant holdings in Hester Biosciences Ltd.

Hester Biosciences Ltd Corporate Actions

View detailed summary of the earnings and dividend history of Hester Biosciences Ltd.

  • Hester Biosciences Ltd Earnings Results

    Hester Biosciences Ltd’s net profit jumped 159.31% since last year same period to ₹16.44Cr in the Q1 2025-2026. On a quarterly growth basis, Hester Biosciences Ltd has generated 1174.42% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Hester Biosciences Ltd Dividends May,2025

    In the quarter ending March 2025, Hester Biosciences Ltd has declared dividend of ₹7.00 per share on 09 May 2025 - translating a dividend yield of 0.81%.

    Read More about Dividends

Indices Featuring Hester Biosciences Ltd Stock

Check stock indices that include Hester Biosciences Ltd.

BSE Healthcare

₹44,827.55

-0.46 (▲-209.37%)

BSE Small-Cap

₹53,882.11

-0.69 (▲-375.87%)

Insights on Hester Biosciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 45.73% to 45.74% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 1.29 Cr → 16.44 Cr (in ₹), with an average increase of 92.2% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 72.0 Cr → 87.47 Cr (in ₹), with an average increase of 9.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.04% to 0.53% in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 112.6% return, outperforming this stock by 132.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 17.1% return, outperforming this stock by 50.3%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 53.73% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, HESTERBIO stock has moved down by -20.8%

About Hester Biosciences Ltd

Hester Pharmaceutical (HPL), established as a private limited company in April 1987 and transitioning to a public limited company in November of 1993, offers a range of veterinary and pharmaceutical products, such as animal health products, poultry vaccines, and laboratory kits and reagents. Furthermore, it markets the veterinary products of up to 10 international companies, including Ghen Corporation (Japan), Maine Biological Laboratories (US), Idexx Corporation (US), and Biogal Galed Laboratories (Israel). Entering the production of veterinary vaccines in vials, HPL also has technical collaborations with Maine Biological Laboratories and Ghen Corporation, and has since received licenses for producing an additional 10 poultry vaccines. To facilitate increased production, HPL has signed a manufacturing agreement with Sinsui Inc. for the production of additional poultry vaccines. Overall, HPL has continued to grow in the years since it was first established.

Revenue: ₹84.11Cr as on June 2025 (Q1 FY26)
Net Profit: ₹17.30Cr as on June 2025 (Q1 FY26)
Listing date: 13 Mar, 2015
OrganisationHester Biosciences Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Hester Biosciences Ltd share price today?

Hester Biosciences Ltd share price today stands at ₹1603.7 as on at the close of the market. Hester Biosciences Ltd share today touched a day high of ₹1637.8 and a low of ₹1599.1.

What is the 52 week high and 52 week low range for Hester Biosciences Ltd share?

Hester Biosciences Ltd touched a 52 week high of ₹2786.1 and a 52 week low of ₹1242.95. Hester Biosciences Ltd share price today i.e. is closed at ₹1603.7, which is -42.44% down from its 52 week high and 29.02% up from its 52 week low.

What is Hester Biosciences Ltd's market capitalisation today?

Hester Biosciences Ltd market capitalisation is ₹1,364.25 Cr as on .

How to buy Hester Biosciences Ltd shares?

To buy Hester Biosciences Ltd shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for HESTERBIO or Hester Biosciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Hester Biosciences Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Hester Biosciences Ltd trading volume today?

Hester Biosciences Ltd trading volume is 2,149.00 as on . This means that 2,149.00 shares of Hester Biosciences Ltd were bought and sold on the stock market during today's trading session.